siRNA knocks down Hsp27 and increases angiotensin II-induced phosphorylated NF-kappaB p65 levels in aortic smooth muscle cells.
ABSTRACT Angiotensin II (Ang II) induces the proinflammatory nuclear factor kappaB (NF-kappaB) in the vasculature. Heat shock and elevated levels of heat shock proteins (Hsps) decrease Ang II-induced NF-kappaB transcriptional activity and inflammation, but little is known about the role of specific Hsps. Here we used small interfering RNA (siRNA) technology to examine the role of Hsp27 in the Ang II-induced NF-kappaB signaling pathway.
Hsp27 siRNA was transfected into rat aortic vascular smooth muscle (A10) and 48 hrs later, the cells were stressed with 100 nM of Ang II for up to 24 hrs. Hsp27 levels were determined by immunofluorescence microscopy and Western analysis and inhibitor kappaB-alpha (I kappaB-alpha), the p65 subunit of NF-kappaB, and I kappaB kinase (IKK) levels were determined by Western analysis.
When Hsp27 was specifically knocked down with Hsp27 siRNA in A10 cells there was a trend toward an increase in Ang II-induced phosphorylated p65. I kappaB-alpha and IKK-beta levels were not changed by the knockdown of Hsp27.
Hsp27 may regulate the phosphorylation of the p65 subunit of NF-kappaB in the Ang II-induced signaling pathway of NF-kappaB in A10 cells. The proinflammatory effects of Ang II on NF-kappaB in vascular smooth muscle cells may be through a non-canonical pathway and be dependent on p65 phosphorylation.
[show abstract] [hide abstract]
ABSTRACT: Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natural compounds that display potent neuroprotective effects, may also alleviate doxorubicin-induced cardiotoxicity. Our in vitro data established that a pretreatment with flavaglines significantly increased viability of doxorubicin-injured H9c2 cardiomyocytes as demonstrated by annexin V, TUNEL and active caspase-3 assays. We demonstrated also that phosphorylation of the small heat shock protein Hsp27 is involved in the mechanism by which flavaglines display their cardioprotective effect. Furthermore, knocking-down Hsp27 in H9c2 cardiomyocytes completely reversed this cardioprotection. Administration of our lead compound (FL3) to mice attenuated cardiomyocyte apoptosis and cardiac fibrosis, as reflected by a 50% decrease of mortality. These results suggest a prophylactic potential of flavaglines to prevent doxorubicin-induced cardiac toxicity.PLoS ONE 01/2011; 6(10):e25302. · 4.09 Impact Factor